1315 Capital

1315 Capital manages over $925 million and provides expansion and growth capital to commercial-stage healthcare services, medical technology, and therapeutics / pharma services companies. The team believes that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses that positively impact patients, physicians, and the broader healthcare system.